CORMORANT ASSET MANAGEMENT, LP – Aerovate Therapeutics, Inc. Transaction History
CORMORANT ASSET MANAGEMENT, LP portfolio value:
$38.64M
portfolio value
CORMORANT ASSET MANAGEMENT, LP quarter portfolio value change:
+6.08%
quarter
Aerovate Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +34.67% | 600K shares | 11.59M | $16.58 | 2.33M |
| Q2 2022 | share | Decrease | -5.46% | -100K shares | -6.50M | $15.63 | 1.73M |
| Q1 2022 | share | 0.00% | 0 shares | 11.97M | $18.33 | 1.83M | |
| Q4 2021 | share | Decrease | -9.85% | -200K shares | -20.37M | $11.19 | 1.83M |
| Q3 2021 | share | 0.00% | 0 shares | -2.65M | $20.98 | 2.03M | |
| Q2 2021 | share | Increase | 0.00% | 2.03M shares | 44.61M | $22.83 | 2.03M |